{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:16:28Z","timestamp":1783070188382,"version":"3.54.6"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00101-012-2136-8","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T10:28:03Z","timestamp":1360751283000},"page":"213-224","source":"Crossref","is-referenced-by-count":31,"title":["Umgang mit Massivblutungen und assoziierten perioperativen Gerinnungsst\u00f6rungen","Dealing with massive bleeding and associated perioperative coagulopathy"],"prefix":"10.1007","volume":"62","author":[{"given":"O.","family":"Grottke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rossaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"2136_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/TA.0b013e31819313bb","volume":"66","author":"Cotton","year":"2009","unstructured":"Cotton BA, Au BK, Nunez TC et al (2009) Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 66:4\u201348","journal-title":"J Trauma"},{"key":"2136_CR2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/TA.0b013e31816c5c80","volume":"64","author":"Cotton","year":"2008","unstructured":"Cotton BA, Gunter OL, Isbell J et al (2008) Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 64:1177\u20131182","journal-title":"J Trauma"},{"key":"2136_CR3","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/TA.0b013e3181a59ad5","volume":"66","author":"Dente","year":"2009","unstructured":"Dente CJ, Shaz BH, Nicholas JM et al (2009) Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 66:1616\u20131624","journal-title":"J Trauma"},{"key":"2136_CR4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/EJA.0b013e32833b1adf","volume":"27","author":"Mellin-Olsen","year":"2010","unstructured":"Mellin-Olsen J, Staender S, Whitaker DK, Smith AF (2010) The Helsinki declaration on patient safety in anaesthesiology. Eur J Anaesthesiol 27:592\u2013597","journal-title":"Eur J Anaesthesiol"},{"key":"2136_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(10)60939-7","volume":"376","author":"Levy","year":"2010","unstructured":"Levy J (2010) Antifibrinolytic therapy: new data and new concepts. Lancet 376:3\u20134","journal-title":"Lancet"},{"key":"2136_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1537-2995.2009.02458.x","volume":"50","author":"Johansson","year":"2010","unstructured":"Johansson P, Stensballe J (2010) Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets \u2013 a review of current literature. Transfusion 50:701\u2013710","journal-title":"Transfusion"},{"key":"2136_CR7","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc8943","volume":"14","author":"Rossaint","year":"2010","unstructured":"Rossaint R, Bouillon B, Cerny V et al; Task Force for Advanced Bleeding Care in Trauma (2010) Management of bleeding following major trauma: an updated European guideline. Crit Care 14:R52","journal-title":"Crit Care"},{"key":"2136_CR8","unstructured":"http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/012019l_S3_Polytrauma_Schwerverletzten-Behandlung_2011\u201307_01.pdf. Zugegriffen: 06. Feb. 2012"},{"key":"2136_CR9","unstructured":"http:\/\/www.bundesaerztekammer.de\/downloads\/Querschnittsleitlinie_Gesamtdokument-deutsch_07032011.pdf. Zugegriffen: 06. Feb. 2012"},{"key":"2136_CR10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TA.0b013e3181d3cc25","volume":"68","author":"Nunez","year":"2010","unstructured":"Nunez TC, Young PP, Holcomb JB, Cotton BA (2010) Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 68:1498\u20131505","journal-title":"J Trauma"},{"key":"2136_CR11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archsurg.143.7.686","volume":"143","author":"O","year":"2008","unstructured":"O\u2019Keeffe T, Refaai M, Tchorz K et al (2008) A massive transfusion protocol to decrease blood component use and costs. Arch Surg 143:686\u2013690","journal-title":"Arch Surg"},{"key":"2136_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ACO.0b013e328336b8d0","volume":"23","author":"Van","year":"2010","unstructured":"Van den Elsen M, Leenen LP, Kesecioglu J (2010) Hemodynamic support of the trauma patient. Curr Opin Anaesth 23:269\u2013275","journal-title":"Curr Opin Anaesth"},{"key":"2136_CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00003246-198306000-00012","volume":"11","author":"Vincent","year":"1983","unstructured":"Vincent JL, Dufaye P, Berre J et al (1983) Serial lactate determinations during circulatory shock. Crit Care Med 11:449\u2013451","journal-title":"Crit Care Med"},{"key":"2136_CR14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00005373-199611000-00001","volume":"41","author":"Davis","year":"1996","unstructured":"Davis JW, Parks SN, Kaups KL et al (1996) Admission base deficit predicts transfusion requirements and risk of complications. J Trauma 41:769\u2013774","journal-title":"J Trauma"},{"key":"2136_CR15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.ta.0000220386.84012.bf","volume":"60","author":"Y\u00fccel","year":"2006","unstructured":"Y\u00fccel N, Lefering R, Maegele M et al (2006) Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 60:1228\u20131236","journal-title":"J Trauma"},{"key":"2136_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1423-0410.2010.01387.x","volume":"100","author":"Maegele","year":"2011","unstructured":"Maegele M, Lefering R, Wafaisade A et al; Trauma Registry of Deutsche Gesellschaft f\u00fcr Unfallchirurgie (TR-DGU) (2011) Revalidation and update of the TASH-Score: a scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury. Vox Sang 100:231\u2013238","journal-title":"Vox Sang"},{"key":"2136_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bpa.2009.09.009","volume":"24","author":"Kozek-Langenecker","year":"2010","unstructured":"Kozek-Langenecker SA (2010) Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 24:27\u201340","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2136_CR18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1213\/ane.0b013e318168b367","volume":"106","author":"Ganter","year":"2008","unstructured":"Ganter MT, Hofer CK (2008) Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106:1366\u20131375","journal-title":"Anesth Analg"},{"key":"2136_CR19","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/cc8948","volume":"14","author":"Sch\u00f6chl","year":"2010","unstructured":"Sch\u00f6chl H, Nienaber U, Hofer G et al (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55","journal-title":"Crit Care"},{"key":"2136_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ALN.0b013e318264c644","volume":"117","author":"Weber","year":"2012","unstructured":"Weber CF, G\u00f6rlinger K, Meininger D et al (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:531\u2013547","journal-title":"Anesthesiology"},{"key":"2136_CR21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1423-0410.2011.01472.x","volume":"101","author":"Levi","year":"2011","unstructured":"Levi M, Fries D, Gombotz H et al (2011) Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang 101:154\u2013174","journal-title":"Vox Sang"},{"key":"2136_CR22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00134-011-2139-y","volume":"37","author":"Lier","year":"2011","unstructured":"Lier H, B\u00f6ttiger BW, Hinkelbein J et al (2011) Coagulation management in multiple trauma: a systematic review. Intensive Care Med 37:572\u2013582","journal-title":"Intensive Care Med"},{"key":"2136_CR23","first-page":"6","volume":"122","author":"Zander","year":"2010","unstructured":"Zander R (2010) Anaemia and massive bleeding apart from the aspect of oxygenation. Wien Klin Wochenschr 122:6\u20138","journal-title":"Wien Klin Wochenschr"},{"key":"2136_CR24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.291.11.1350","volume":"291","author":"Cooper","year":"2004","unstructured":"Cooper DJ, Myles PS, McDermott FT et al (2004) HTS study investigators. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291:1350\u20131357","journal-title":"JAMA"},{"key":"2136_CR25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2010.1405","volume":"304","author":"Bulger","year":"2010","unstructured":"Bulger EM, May S, Brasel KJ et al (2010) ROC investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 304:1455\u20131464","journal-title":"JAMA"},{"key":"2136_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/SLA.0b013e3181fcdb22","volume":"253","author":"Bulger","year":"2011","unstructured":"Bulger EM, May S, Kerby JD et al (2011) ROC investigators. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 253:431\u2013441","journal-title":"Ann Surg"},{"key":"2136_CR27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcrc.2010.08.021","volume":"26","author":"Morrison","year":"2011","unstructured":"Morrison LJ, Baker AJ, Rhind SG et al (2011) The Toronto prehospital hypertonic resuscitation-head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. J Crit Care 26:363\u2013372","journal-title":"J Crit Care"},{"key":"2136_CR28","first-page":"CD000567","volume":"3","author":"Perel","year":"2011","unstructured":"Perel P, Roberts I (2011) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 3:CD000567","journal-title":"Cochrane Database Syst Rev"},{"key":"2136_CR29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/bja\/aer229","volume":"107","author":"James","year":"2011","unstructured":"James MF, Michell WL, Joubert IA et al (2011) Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107:693\u2013702","journal-title":"Br J Anaesth"},{"key":"2136_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjsurg.2010.05.002","volume":"202","author":"Lissauer","year":"2011","unstructured":"Lissauer ME, Chi A, Kramer ME et al (2011) Association of 6% hetastarch resuscitation with adverse outcomes in critically ill trauma patients. Am J Surg 202:53\u201358","journal-title":"Am J Surg"},{"key":"2136_CR31","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.TA.0000064328.97941.FC","volume":"56","author":"Wolberg","year":"2004","unstructured":"Wolberg AS, Meng ZH, Monroe DM III, Hoffman M (2004) A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56:1221\u20131128","journal-title":"J Trauma"},{"key":"2136_CR32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/bja\/aei169","volume":"95","author":"Spahn","year":"2005","unstructured":"Spahn DR, Rossaint R (2005) Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95:130\u2013139","journal-title":"Br J Anaesth"},{"key":"2136_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0749-0704(03)00095-2","volume":"20","author":"Schreiber","year":"2004","unstructured":"Schreiber MA (2004) Damage control surgery. Crit Care Clin 20:101\u2013118","journal-title":"Crit Care Clin"},{"key":"2136_CR34","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.TA.0000066184.20808.A5","volume":"55","author":"Meng","year":"2003","unstructured":"Meng ZH, Wolberg AS, Monroe DM, Hoffman M (2003) The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55:886\u2013891","journal-title":"J Trauma"},{"key":"2136_CR35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.ta.0000226739.30655.75","volume":"61","author":"Engstrom","year":"2006","unstructured":"Engstrom M, Schott U, Romner B et al (2006) Acidosis impairs the coagulation: a thromboelastographic study. J Trauma 61:624\u2013628","journal-title":"J Trauma"},{"key":"2136_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.ta.0000250497.08101.8b","volume":"62","author":"Gonzalez","year":"2007","unstructured":"Gonzalez EA, Moore FA, Holcomb JB et al (2007) Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 62:112\u2013119","journal-title":"J Trauma"},{"key":"2136_CR37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/TA.0b013e318187e15b","volume":"65","author":"Lier","year":"2008","unstructured":"Lier H, Krep H, Schroeder S, Stuber F (2008) Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia and hypothermia on functional hemostasis in trauma. J Trauma 65:951\u2013960","journal-title":"J Trauma"},{"key":"2136_CR38","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1097\/01.CCM.0000171840.01892.36","volume":"33","author":"Vivien","year":"2005","unstructured":"Vivien B, Langeron O, Morell E et al (2005) Early hypocalcemia in severe trauma. Crit Care Med 33:1946\u20131952","journal-title":"Crit Care Med"},{"key":"2136_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","volume":"340","author":"H\u00e9bert","year":"1999","unstructured":"H\u00e9bert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409\u2013417","journal-title":"N Engl J Med"},{"key":"2136_CR40","first-page":"CD002042","volume":"10","author":"Carless","year":"2010","unstructured":"Carless PA, Henry DA, Carson JL et al (2010) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 10:CD002042","journal-title":"Cochrane Database Syst Rev"},{"key":"2136_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CCM.0b013e31817da7dc","volume":"36","author":"Beekley","year":"2008","unstructured":"Beekley AC (2008) Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med 36:267\u2013274","journal-title":"Crit Care Med"},{"key":"2136_CR42","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1537-2995.2006.01026.x","volume":"46","author":"Tinmouth","year":"2006","unstructured":"Tinmouth A, Fergusson D, Yee IC et al (2006) Clinical consequences of red cell storage in the critically ill. Transfusion 46:2014\u20132027","journal-title":"Transfusion"},{"key":"2136_CR43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF03021526","volume":"53","author":"Hardy","year":"2006","unstructured":"Hardy JF, Moerloose P de, Samama CM (2006) Members of the Groupe d\u2019Int\u00e9r\u00eat en H\u00e9mostase P\u00e9riop\u00e9ratoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 53:40\u201358","journal-title":"Can J Anaesth"},{"key":"2136_CR44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2044.2010.06367.x","volume":"65","author":"Hanke","year":"2010","unstructured":"Hanke AA, Dellweg C, Kienbaum P et al (2010) Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. Anaesthesia 65:688\u2013691","journal-title":"Anaesthesia"},{"key":"2136_CR45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","volume":"126","author":"Stanworth","year":"2004","unstructured":"Stanworth SJ, Brunskill SJ, Hyde CJ et al (2004) Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126:139\u2013152","journal-title":"Br J Haematol"},{"key":"2136_CR46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/SLA.0b013e318185a9ad","volume":"248","author":"Holcomb","year":"2008","unstructured":"Holcomb JB, Wade CE, Michalek JE et al (2008) Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 248:447\u2013458","journal-title":"Ann Surg"},{"key":"2136_CR47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/TA.0b013e3181271ba3","volume":"63","author":"Borgman","year":"2007","unstructured":"Borgman MA, Spinella PC, Perkins JG et al (2007) The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63:805\u2013813","journal-title":"J Trauma"},{"key":"2136_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/TA.0b013e318196c3ac","volume":"66","author":"Snyder","year":"2009","unstructured":"Snyder CW, Weinberg JA, McGwin G Jr et al (2009) The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 66:358\u2013362","journal-title":"J Trauma"},{"key":"2136_CR49","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1537-2995.2010.02630.x","volume":"50","author":"Murad","year":"2010","unstructured":"Murad MH, Stubbs JR, Gandhi MJ et al (2010) The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 50:1370\u20131383","journal-title":"Transfusion"},{"key":"2136_CR50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.blre.2009.07.003","volume":"23","author":"Spinella","year":"2009","unstructured":"Spinella PC, Holcomb JB (2009) Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 23:231\u2013240","journal-title":"Blood Rev"},{"key":"2136_CR51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/TA.0b013e3181878028","volume":"65","author":"Sperry","year":"2008","unstructured":"Sperry JL, Ochoa JB, Gunn SR et al (2008) An FFP:PRBC transfusion ratio >\/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 65:986\u2013993","journal-title":"J Trauma"},{"key":"2136_CR52","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/CCM.0b013e318168f89d","volume":"36","author":"Sarani","year":"2008","unstructured":"Sarani B, Dunkman WJ, Dean L et al (2008) Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 36:1114\u20131118","journal-title":"Crit Care Med"},{"key":"2136_CR53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1423-0410.2009.01167.x","volume":"96","author":"Shanwell","year":"2009","unstructured":"Shanwell A, Andersson TM, Rostgaard K et al (2009) Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang 96:316\u2013323","journal-title":"Vox Sang"},{"key":"2136_CR54","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.2010.175","volume":"145","author":"Inaba","year":"2010","unstructured":"Inaba K, Branco BC, Rhee P et al (2010) Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 145:899\u2013906","journal-title":"Arch Surg"},{"key":"2136_CR55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ACO.0b013e32832678d9","volume":"22","author":"Fries","year":"2009","unstructured":"Fries D, Innerhofer P, Schobersberger W (2009) Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 22:267\u2013274","journal-title":"Curr Opin Anaesthesiol"},{"key":"2136_CR56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5482\/ha-1178","volume":"32","author":"Sch\u00f6chl","year":"2012","unstructured":"Sch\u00f6chl H, Voelckel W, Maegele M, Solomon C (2012) Trauma-associated hyperfibrinolysis. Hamostaseologie 32:22\u201327","journal-title":"Hamostaseologie"},{"key":"2136_CR57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/TA.0b013e31818b2483","volume":"67","author":"Sch\u00f6chl","year":"2009","unstructured":"Sch\u00f6chl H, Frietsch T, Pavelka M, J\u00e1mbor C (2009) Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 67:125\u2013131","journal-title":"J Trauma"},{"key":"2136_CR58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/TA.0b013e31822114af","volume":"71","author":"Cap","year":"2011","unstructured":"Cap AP, Baer DG, Orman JA et al (2011) Tranexamic acid for trauma patients: a critical review of the literature. J Trauma 71:9\u201314","journal-title":"J Trauma"},{"key":"2136_CR59","doi-asserted-by":"crossref","unstructured":"CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23\u201332","DOI":"10.1016\/S0140-6736(10)60835-5"},{"key":"2136_CR60","doi-asserted-by":"crossref","unstructured":"CRASH-2 trial collaborators (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377:1096\u20131101","DOI":"10.1016\/S0140-6736(11)60278-X"},{"key":"2136_CR61","first-page":"CD001886","volume":"3","author":"Henry","year":"2011","unstructured":"Henry DA, Carless PA, Moxey AJ et al (2011) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 3:CD001886","journal-title":"Cochrane Database Syst Rev"},{"key":"2136_CR62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/JPM.2008.093","volume":"36","author":"Henrich","year":"2008","unstructured":"Henrich W, Surbek D, Kainer F et al (2008) Diagnosis and treatment of peripartum bleeding. J Perinat Med 36:467\u2013478","journal-title":"J Perinat Med"},{"key":"2136_CR63","first-page":"360","volume":"81","author":"Hiippala","year":"1995","unstructured":"Hiippala ST, Myllyl\u00e4 GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360\u2013365","journal-title":"Anesth Analg"},{"key":"2136_CR64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/bja\/aei160","volume":"95","author":"Fries","year":"2005","unstructured":"Fries D, Krismer A, Klingler A et al (2005) Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 95:172\u2013177","journal-title":"Br J Anaesth"},{"key":"2136_CR65","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2007.02481.x","volume":"5","author":"Velik-Salchner","year":"2007","unstructured":"Velik-Salchner C, Haas T, Innerhofer P et al (2007) The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5:1019\u20131025","journal-title":"J Thromb Haemost"},{"key":"2136_CR66","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc8960","volume":"14","author":"Grottke","year":"2010","unstructured":"Grottke O, Braunschweig T, Henzler D et al (2010) Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 14:R62","journal-title":"Crit Care"},{"key":"2136_CR67","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/cc10488","volume":"15","author":"Kozek-Langenecker","year":"2011","unstructured":"Kozek-Langenecker S, S\u00f8rensen B, Hess JR, Spahn DR (2011) Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 15:R239","journal-title":"Crit Care"},{"key":"2136_CR68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/1076029609336855","volume":"16","author":"Adam","year":"2010","unstructured":"Adam S, Karger R, Kretschmer V (2010) Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 16:454-460","journal-title":"Clin Appl Thromb Hemost"},{"key":"2136_CR69","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1742-1241.2008.01859.x","volume":"62","author":"Kalina","year":"2008","unstructured":"Kalina U, Bickhard H, Schulte S (2008) Biochemical comparison of seven commercially available prothrombin complex concentrates. Int J Clin Pract 62:1614\u20131622","journal-title":"Int J Clin Pract"},{"key":"2136_CR70","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/cc6987","volume":"12","author":"Bruce","year":"2008","unstructured":"Bruce D, Nokes TJ (2008) Prothrombin complex concentrate (Beriplex P\/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 12:R105","journal-title":"Crit Care"},{"key":"2136_CR71","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc8186","volume":"13","author":"Schick","year":"2009","unstructured":"Schick KS, Fertmann JM, Jauch KW, Hoffmann JN (2009) Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 13:R191","journal-title":"Crit Care"},{"key":"2136_CR72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/bja\/aen391","volume":"102","author":"Dickneite","year":"2009","unstructured":"Dickneite G, Pragst I (2009) Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 102:345\u2013354","journal-title":"Br J Anaesth"},{"key":"2136_CR73","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1213\/ane.0b013e318165dfbb","volume":"106","author":"Dickneite","year":"2008","unstructured":"Dickneite G, Doerr B, Kaspereit F (2008) Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth Analg 106:1070\u20131077","journal-title":"Anesth Analg"},{"key":"2136_CR74","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1160\/TH11-02-0101","volume":"106","author":"Honickel","year":"2011","unstructured":"Honickel M, Rieg A, Rossaint R et al (2011) Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thromb Haemost 106:724\u2013733","journal-title":"Thromb Haemost"},{"key":"2136_CR75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1538-7836.2011.04211.x","volume":"9","author":"Mitterlechner","year":"2011","unstructured":"Mitterlechner T, Innerhofer P, Streif W et al (2011) Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 9:729\u2013737","journal-title":"J Thromb Haemost"},{"key":"2136_CR76","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2011-03-343046","volume":"118","author":"Grottke","year":"2011","unstructured":"Grottke O, Braunschweig T, Spronk HM et al (2011) Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 118:1943\u20131951","journal-title":"Blood"},{"key":"2136_CR77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2044.2009.06188.x","volume":"65","author":"Sch\u00f6chl","year":"2010","unstructured":"Sch\u00f6chl H, Forster L, Woidke R et al (2010) Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 65:199\u2013203","journal-title":"Anaesthesia"},{"key":"2136_CR78","first-page":"112","volume":"1","author":"Hedner","year":"2003","unstructured":"Hedner U, Erhardtsen E (2003) Potential role of recombinant factor VIIa as a hemostatic agent. Clin Adv Hematol Oncol 1:112\u2013119","journal-title":"Clin Adv Hematol Oncol"},{"key":"2136_CR79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpa.2009.09.005","volume":"24","author":"Grottke","year":"2010","unstructured":"Grottke O, Henzler D, Rossaint R (2010) Activated recombinant factor VII (rFVIIa). Best Pract Res Clin Anaesthesiol 24:95\u2013106","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2136_CR80","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","volume":"53","author":"Franchini","year":"2010","unstructured":"Franchini M, Franchi M, Bergamini V et al (2010) The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 53:219\u2013227","journal-title":"Clin Obstet Gynecol"},{"key":"2136_CR81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","volume":"59","author":"Boffard","year":"2005","unstructured":"Boffard KD, Riou B, Warren B et al; NovoSeven Trauma Study Group (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8\u201315","journal-title":"J Trauma"},{"key":"2136_CR82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/TA.0b013e3181edf36e","volume":"69","author":"Hauser","year":"2010","unstructured":"Hauser CJ, Boffard K, Dutton R et al; CONTROL Study Group (2010) Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 69:489\u2013500","journal-title":"J Trauma"},{"key":"2136_CR83","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","volume":"363","author":"Levi","year":"2010","unstructured":"Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791\u20131800","journal-title":"N Engl J Med"},{"key":"2136_CR84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","volume":"295","author":"O","year":"2006","unstructured":"O\u2019Connell KA, Wood JJ, Wise RP et al (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295:293\u2013298","journal-title":"JAMA"},{"key":"2136_CR85","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","volume":"154","author":"Yank","year":"2011","unstructured":"Yank V, Tuohy CV, Logan AC et al (2011) Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 154:529\u2013540","journal-title":"Ann Intern Med"},{"key":"2136_CR86","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/cc5026","volume":"10","author":"Vincent","year":"2006","unstructured":"Vincent JL, Rossaint R, Riou B et al (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding \u2013 a European perspective. Crit Care 10:R120","journal-title":"Crit Care"},{"key":"2136_CR87","first-page":"CD001884","volume":"1","author":"Carless","year":"2004","unstructured":"Carless PA, Henry DA, Moxey AJ et al (2004) Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 1:CD001884","journal-title":"Cochrane Database Syst Rev"},{"key":"2136_CR88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.2006.02667.x","volume":"62","author":"Liesenfeld","year":"2006","unstructured":"Liesenfeld KH, Sch\u00e4fer HG, Troc\u00f3niz IF et al (2006) Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis. Br J Clin Pharmacol 62:527\u2013537","journal-title":"Br J Clin Pharmacol"},{"key":"2136_CR89","unstructured":"http:\/\/www.bfarm.de\/DE\/Pharmakovigilanz\/blutPradaxa\/blutPradaxa-inhalt.html. Zugegriffen: 19. Dez. 2012"},{"key":"2136_CR90","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","volume":"124","author":"Eerenberg","year":"2011","unstructured":"Eerenberg ES, Kamphuisen PW, Sijpkens MK et al (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124:1573\u20131579","journal-title":"Circulation"},{"key":"2136_CR91","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.thromres.2008.07.007","volume":"123","author":"Desmurs-Clavel","year":"2009","unstructured":"Desmurs-Clavel H, Huchon C, Chatard B et al (2009) Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC. Thromb Res 123:796\u2013798","journal-title":"Thromb Res"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-012-2136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-012-2136-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-012-2136-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:40:10Z","timestamp":1644334810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-012-2136-8"}},"subtitle":["Handlungsempfehlung der Deutschen Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin","Recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine"],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1007\/s00101-012-2136-8","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}